Syncytiotrophoblast Functions and Fetal Growth Restriction during Placental Malaria: Updates and Implication for Future Interventions

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Kidima, Winifrida B ^a  

^a UNIVERSITY OF DAR ES SALAAM   (Tanzania)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; ANGIOPOIETIN 1; ANGIOPOIETIN 2; CRYOPYRIN; GAMMA INTERFERON; HEMOZOIN; INSULIN; INTERLEUKIN 2; MAMMALIAN TARGET OF RAPAMYCIN; NITRIC OXIDE SYNTHASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLACENTAL GROWTH FACTOR; RAPAMYCIN; SOMATOMEDIN C; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6; TRANSFORMING GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; APOPTOSIS; CELL FUNCTION; CELL METABOLISM; CELL SURVIVAL; FETUS GROWTH; HUMAN; IN VITRO STUDY; INTRAUTERINE GROWTH RETARDATION; MATERNAL NUTRITION; NONHUMAN; PATHOGENESIS; PLACENTA MALARIA; PLASMODIUM BERGHEI; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; SYNCYTIOTROPHOBLAST; FEMALE; FETAL GROWTH RETARDATION; MALARIA; METABOLISM; MORTALITY; PARASITOLOGY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TROPHOBLAST;

FEMALE; FETAL GROWTH RETARDATION; HUMANS; MALARIA; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TROPHOBLASTS;

EID: 84947483899     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/451735     Document Type: Review

References (89)

1. H. L. Guyatt and R. W. Snow, "Impact of malaria during pregnancy on low birth weight in Sub-Saharan Africa, " Clinical Microbiology Reviews, vol. 17, no. 4, pp. 760-769, 2004.
2. M. Militello, E. M. Pappalardo, S. Ermito, A. Dinatale, A. Cavaliere, and S. Carrara, "Obstetric management of IUGR, " Journal of Prenatal Medicine, vol. 3, no. 1, pp. 6-9, 2009.
3. R. W. Steketee, B. L. Nahlen, M. E. Parise, and C. Menendez, "The burden ofmalaria in pregnancy inmalaria-endemic areas, " TheAmerican Journal of Tropical Medicine andHygiene, vol. 64, supplement, no. 1-2, pp. 28-35, 2001.
4. D. L. Christensen, A. Kapur, and I. C. Bygbjerg, "Physiological adaption to maternal malaria and other adverse exposure: low birthweight, functional capacity, and possible metabolic disease in adult life, " International Journal of Gynecology and Obstetrics, vol. 115, supplement 1, pp. S16-S19, 2011.
5. J. L. Morrison, J. A. Duffield, B. S. Muhlhausler, S. Gentili, and I. C. McMillen, "Fetal growth restriction, catch-up growth and the early origins of insulin resistance and visceral obesity, " Pediatric Nephrology, vol. 25, no. 4, pp. 669-677, 2010.
6. B. Gamain, A. R. Trimnell, C. Scheidig, A. Schert, L. H. Miller, and J. D. Smith, "Identification of multiple chondroitin sulfate A (CSA)-binding domains in the var2CSA gene transcribed in CSA-binding parasites, " Journal of Infectious Diseases, vol. 191, no. 6, pp. 1010-1013, 2005.
7. J. G. Beeson, S. J. Rogerson, B. M. Cooke et al., "Adhesion of Plasmodium falciparum-infected erythrocytes to hyaluronic acid in placentalmalaria, " Nature Medicine, vol. 6, no. 1, pp. 86-90, 2000.
8. M. Fried and P. E. Duffy, "Adherence of Plasmodium falciparum to chondroitin sulfate A in the human placenta, " Science, vol. 272, no. 5267, pp. 1502-1504, 1996.
9. J. G. Beeson, S. J. Rogerson, and G. V. Brown, "Evaluating specific adhesion of Plasmodium falciparum-infected erythrocytes to immobilised hyaluronic acid with comparison to binding of mammalian cells, " International Journal for Parasitology, vol. 32, no. 10, pp. 1245-1252, 2002.
10. P. Magistrado, A. Salanti, N. G. Tuikue Ndam et al., "VAR2CSA expression on the surface of placenta-derived Plasmodium falciparum-infected erythrocytes, " Journal of InfectiousDiseases, vol. 198, no. 7, pp. 1071-1074, 2008.
11. N. K. Viebig, E. Levin, S. Dechavanne et al., "Disruption of Var2CSA gene impairs placental malaria associated adhesion phenotype, " PLoS ONE, vol. 2, no. 9, article e910, 2007.
12. A. Salanti, M. Dahlbäck, L. Turner et al., "Evidence for the involvement of VAR2CSA in pregnancy-associated malaria, " Journal of ExperimentalMedicine, vol. 200, no. 9, pp. 1197-1203, 2004.
13. M. Fried, G. J. Domingo, C. D. Gowda, T. K. Mutabingwa, and P. E. Duffy, "Plasmodium falciparum: chondroitin sulfate A is the major receptor for adhesion of parasitized erythrocytes in the placenta, " Experimental Parasitology, vol. 113, no. 1, pp. 36-42, 2006.
14. J. Zhu, G. Krishnegowda, G. Li, and D. Channe Gowda, "Proinflammatory responses by glycosylphosphatidylinositols (GPIs) of Plasmodium falciparum aremainly mediated through the recognition of TLR2/TLR1, " Experimental Parasitology, vol. 128, no. 3, pp. 205-211, 2011.
15. P. Parroche, F. N. Lauw, N. Goutagny et al., "Malariahemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9, " Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 6, pp. 1919-1924, 2007.
16. C. Coban, Y. Igari, M. Yagi et al., "Immunogenicity of wholeparasite vaccines against Plasmodium falciparum Involves malarial hemozoin and host TLR9, " Cell Host and Microbe, vol. 7, no. 1, pp. 50-61, 2010.
17. C. Dostert, G. Guarda, J. F. Romero et al., "Malarial hemozoin is a Nalp3 inflammasome activating danger signal, " PLoS ONE, vol. 4, no. 8, article e6510, 2009.
18. M. Fried, R. O. Muga, A. O. Misore, and P. E. Duffy, "Malaria elicits type 1 cytokines in the human placenta: IFN-gamma and TNF-alpha associatedwith pregnancy outcomes, "TheJournal of Immunology, vol. 160, no. 5, pp. 2523-2530, 1998.
19. E. T. Abrams, H. Brown, S. W. Chensue et al., "Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated chemokine expression, " Journal of Immunology, vol. 170, no. 5, pp. 2759-2764, 2003.
20. A. L. Suguitan Jr., R. G. F. Leke, G. Fouda et al., "Changes in the levels of chemokines and cytokines in the placentas of women with Plasmodium falciparum malaria, " Journal of Infectious Diseases, vol. 188, no. 7, pp. 1074-1082, 2003.
21. A. L. Suguitan Jr., T. J. Cadigan, T. A. Nguyen et al., "Malariaassociated cytokine changes in the placenta of women with preterm deliveries in Yaounde, Cameroon, " The American Journal of Tropical Medicine and Hygiene, vol. 69, no. 6, pp. 574-581, 2003.
22. S. J. Rogerson, H. C. Brown, E. Pollina et al., "Placental tumor necrosis factor alpha but not gamma interferon is associated with placental malaria and low birth weight in Malawian women, " Infection and Immunity, vol. 71, no. 1, pp. 267-270, 2003.
23. J. N. Bulmer, F. N. Rasheed, N. Francis, L. Morrison, and B. M. Greenwood, "Placental malaria. I. Pathological classification, " Histopathology, vol. 22, no. 3, pp. 211-218, 1993.
24. C. Menendez, J. Ordi, M. R. Ismail et al., "The impact of placental malaria on gestational age and birth weight, " The Journal of InfectiousDiseases, vol. 181, no. 5, pp. 1740-1745, 2000.
25. P. R. Walter, Y. Garin, and P. Blot, "Placental pathologic changes in malaria. A histologic and ultrastructural study, " American Journal of Pathology, vol. 109, no. 3, pp. 330-342, 1982.
26. M. R. Ismail, J. Ordi, C. Menendez et al., "Placental pathology in malaria: a histological, immunohistochemical, and quantitative study, " Human Pathology, vol. 31, no. 1, pp. 85-93, 2000.
27. S. J. Rogerson, E. Pollina, A. Getachew, E. Tadesse, V. M. Lema, and M. E. Molyneux, "Placental monocyte infiltrates in response to Plasmodium falciparum malaria infection and their association with adverse pregnancy outcomes, " The American Journal of TropicalMedicine and Hygiene, vol. 68, no. 1, pp. 115-119, 2003.
28. E. T. Abrams, H. Brown, S. W. Chensue et al., "Host response to malaria during pregnancy: placental monocyte recruitment is associated with elevated chemokine expression, " The Journal of Immunology, vol. 170, no. 5, pp. 2759-2764, 2003.
29. J. Ordi, C. Menendez, M. R. Ismail et al., "Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells, " Journal of Infectious Diseases, vol. 183, no. 7, pp. 1100-1107, 2001.
30. J. N. Bulmer, F. N. Rasheed, L. Morrison, N. Francis, and B. M. Greenwood, "Placental malaria. II. A semi-quantitative investigation of the pathological features, " Histopathology, vol. 22, no. 3, pp. 219-225, 1993.
31. I. P. Crocker, O. M. Tanner, J. E. Myers, J. N. Bulmer, G. Walraven, and P. N. Baker, "Syncytiotrophoblast degradation and the pathophysiology of the malaria-infected placenta, " Placenta, vol. 25, no. 4, pp. 273-282, 2004.
32. S. Chaikitgosiyakul, M. J. Rijken, A. Muehlenbachs et al., "A morphometric and histological study of placental malaria shows significant changes to villous architecture in both Plasmodium falciparum and Plasmodium vivax infection, " Malaria Journal, vol. 13, article 4, 2014.
33. N. W. Lucchi, D. Sarr, S. O. Owino, S. M. Mwalimu, D. S. Peterson, and J. M. Moore, "Natural hemozoin stimulates syncytiotrophoblast to secrete chemokines and recruit peripheral blood mononuclear cells, " Placenta, vol. 32, no. 8, pp. 579-585, 2011.
34. N. W. Lucchi, D. S. Peterson, and J. M. Moore, "Immunologic activation of human syncytiotrophoblast by Plasmodium falciparum, " Malaria Journal, vol. 7, article 42, 2008.
35. N. W. Lucchi, R. Koopman, D. S. Peterson, and J. M. Moore, "Plasmodium falciparum-infected red blood cells selected for binding to cultured syncytiotrophoblast bind to chondroitin sulfate A and induce tyrosine phosphorylation in the syncytiotrophoblast, " Placenta, vol. 27, no. 4-5, pp. 384-394, 2006.
36. G. Aboagye-Mathiesen, F. D. Tth, P. M. Petersen, and P. Ebbesen, "Human trophoblast interferons: production, purification, and biochemical characterization, " Placenta, vol. 15, no. 1, pp. 315-329, 1994.
37. V. M. Abrahams and G. Mor, "Toll-like receptors and their role in the trophoblast, " Placenta, vol. 26, no. 7, pp. 540-547, 2005.
38. F. Deng, F. Han, and C. Wu, "Expression and immune effect of toll-like receptor 4 in human trophoblast cells, " Journal of HuazhongUniversity of Science and Technology:Medical Science, vol. 29, no. 3, pp. 359-362, 2009.
39. S. Komine-Aizawa, H. Majima, C. Yoshida-Noro, and S. Hayakawa, "Stimuli through Toll-like receptor (TLR) 3 and 9 affect human chorionic gonadotropin (hCG) production in a choriocarcinoma cell line, " Journal of Obstetrics and Gynaecology Research, vol. 34, no. 2, pp. 144-151, 2008.
40. M. Mulla, K. Myrtolli, J. Potter et al., "Uric acid induces trophoblast IL-1 production via the inflammasome: implications for the pathogenesis of preeclampsia, " American Journal of Reproductive Immunology, vol. 65, no. 6, pp. 542-548, 2015.
41. V. M. Abrahams, "Pattern recognition at the maternal-fetal interface, " Immunological Investigations, vol. 37, no. 5-6, pp. 427-447, 2008.
42. V. M. Abrahams, P. B. Aldo, S. P. Murphy et al., "TLR6 modulates first trimester trophoblast responses to peptidoglycan, " Journal of Immunology, vol. 180, no. 9, pp. 6035-6043, 2008.
43. R. T. Gazzinelli, P. Kalantari, K. A. Fitzgerald, and D. T. Golenbock, "Innate sensing of malaria parasites, " Nature Reviews Immunology, vol. 14, no. 11, pp. 744-757, 2014.
44. R. McGready, S. J. Lee, J. Wiladphaingern et al., "Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study, " The Lancet Infectious Diseases, vol. 12, no. 5, pp. 388-396, 2012.
45. P. Chatterjee, L. E. Weaver, K. M. Doersch et al., "Placental Tolllike receptor 3 and Toll-like receptor 7/8 activation contributes to preeclampsia in humans and mice, " PLoS ONE, vol. 7, no. 7, Article ID e41884, 9 pages, 2012.
46. D. L. Economides and K. H. Nicolaides, "Blood glucose and oxygen tension levels in small-for-gestational-age fetuses, " American Journal of Obstetrics and Gynecology, vol. 160, no. 2, pp. 385-389, 1989.
47. T. Jansson, K. Ylvén, M. Wennergren, and T. L. Powell, "Glucose transport and system A activity in syncytiotrophoblast microvillous and basal plasma membranes in intrauterine growth restriction, " Placenta, vol. 23, no. 5, pp. 392-399, 2002.
48. P. Boeuf, E. H. Aitken, U. Chandrasiri et al., "Plasmodium falciparum malaria elicits inflammatory responses that dysregulate placental amino acid transport, " PLoS Pathogens, vol. 9, no. 2, Article ID e1003153, 2013.
49. S. Lager and T. L. Powell, "Regulation of nutrient transport across the placenta, " Journal of Pregnancy, vol. 2012, Article ID 179827, 14 pages, 2012.
50. A. S. Cerdeira and S. A. Karumanchi, "Angiogenic factors in preeclampsia and related disorders, " Cold Spring Harbor Perspectives in Medicine, vol. 2, no. 11, Article ID a006585, 2012.
51. C. E. Powe, R. J. Levine, and S. A. Karumanchi, "Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease, " Circulation, vol. 123, no. 24, pp. 2856-2869, 2011.
52. D. Kappou, S. Sifakis, A. Konstantinidou, N. Papantoniou, and D. A. Spandidos, "Role of the angiopoietin/Tie system in pregnancy (Review), " Experimental and Therapeutic Medicine, vol. 9, no. 4, pp. 1091-1096, 2015.
53. E. K. Dorman, C. E. Shulman, J. Kingdom et al., "Impaired uteroplacental blood flow in pregnancies complicated by falciparum malaria, " Ultrasound in Obstetrics and Gynecology, vol. 19, no. 2, pp. 165-170, 2002.
54. T. Todros, A. Sciarrone, E. Piccoli, C. Guiot, P. Kaufmann, and J. Kingdom, "Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction, " Obstetrics&Gynecology, vol. 93, no. 4, pp. 499-503, 1999.
55. A. L. Conroy, K. L. Silver, K. Zhong et al., "Complement activation and the resulting placental vascular insufficiency drives fetal growth restriction associated with placental malaria, " Cell Host and Microbe, vol. 13, no. 2, pp. 215-226, 2013.
56. P. Boeuf, A. Tan, C. Romagosa et al., "Placental hypoxia during placental malaria, " Journal of Infectious Diseases, vol. 197, no. 5, pp. 757-765, 2008.
57. R. Neres, C. R. F. Marinho, L. A. Gonçalves, M. B. Catarino, and C. Penha-Gonçalves, "Pregnancy outcome and placenta pathology in Plasmodium berghei ANKA infected mice reproduce the pathogenesis of severe malaria in pregnant women, " PLoS ONE, vol. 3, no. 2, article e1608, 2008.
58. K. L. Silver, K. Zhong, R. G. F. Leke, D. W. Taylor, and K. C. Kain, "Dysregulation of angiopoietins is associated with placental malaria and low birth weight, " PLoS ONE, vol. 5, no. 3, Article ID e9481, 2010.
59. A. Muehlenbachs, T. K. Mutabingwa, S. Edmonds, M. Fried, and P. E. Duffy, "Hypertension and maternal-fetal conflict during placental malaria, " PLoS Medicine, vol. 3, no. 11, article e446, 2006.
60. K. L. Silver, A. L. Conroy, R. G. F. Leke et al., "Circulating soluble endoglin levels in pregnant women in Cameroon andMalawi-associations with placentalmalaria and fetal growth restriction, " PLoS ONE, vol. 6, no. 9, Article ID e24985, 2011.
61. W. B. Kidima, Malaria associated changes in fetal syncytiotrophoblast function [Ph. D. dissertation], Department of Tropical MedicineMedicalMicrobiology and Pharmacology, University of Hawaii at Manoa, 2013.
62. A. L. Fowden, "The insulin-like growth factors and fetoplacental growth, " Placenta, vol. 24, no. 8-9, pp. 803-812, 2003.
63. V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton, "Endocrine regulation of human fetal growth: the role of the mother, placenta, and fetus, " Endocrine Reviews, vol. 27, no. 2, pp. 141-169, 2006.
64. K. A. Woods, C. Camacho-Hübner, M. O. Savage, and A. J. L. Clark, "Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene, " The New England Journal of Medicine, vol. 335, no. 18, pp. 1363-1367, 1996.
65. M. M. H. Lau, C. E. H. Stewart, Z. Liu, H. Bhatt, P. Rotwein, and C. L. Stewart, "Loss of the imprinted IGF2/cation-independent mannose 6-phosphate receptor results in fetal overgrowth and perinatal lethality, " Genes & Development, vol. 8, no. 24, pp. 2953-2963, 1994.
66. L. Laviola, S. Perrini, G. Belsanti et al., "Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling, " Endocrinology, vol. 146, no. 3, pp. 1498-1505, 2005.
67. C. Chiesa, J. F. Osborn, C. Haass et al., "Ghrelin, leptin, IGF-1, IGFBP-3, and insulin concentrations at birth: is there a relationship with fetal growth and neonatal anthropometry?" Clinical Chemistry, vol. 54, no. 3, pp. 550-558, 2008.
68. A. J. Umbers, P. Boeuf, C. Clapham et al., "Placental malariaassociated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation, " Journal of Infectious Diseases, vol. 203, no. 4, pp. 561-569, 2011.
69. M. Laplante and D. M. Sabatini, "mTOR signaling at a glance, " Journal of Cell Science, vol. 122, no. 20, pp. 3589-3594, 2009.
70. J. Huang, C. C. Dibble, M. Matsuzaki, and B. D. Manning, "The TSC1-TSC2 complex is required for proper activation of mTOR complex 2, " Molecular and Cellular Biology, vol. 28, no. 12, pp. 4104-4115, 2008.
71. J. D. Powell, K. N. Pollizzi, E. B. Heikamp, and M. R. Horton, "Regulation of immune responses bymTOR, " Annual Review of Immunology, vol. 30, pp. 39-68, 2012.
72. S. Wullschleger, R. Loewith, and M. N. Hall, "TOR signaling in growth andmetabolism, " Cell, vol. 124, no. 3, pp. 471-484, 2006.
73. D. A. Guertin and D. M. Sabatini, "Defining the role of mTOR in cancer, " Cancer Cell, vol. 12, no. 1, pp. 9-22, 2007.
74. M. Laplante and D. M. Sabatini, "MTOR signaling in growth control and disease, " Cell, vol. 149, no. 2, pp. 274-293, 2013.
75. Y. Dobashi, Y. Watanabe, C. Miwa, S. Suzuki, and S. Koyama, "Mammalian target of rapamycin: a central node of complex signaling cascades, " International Journal of Clinical and Experimental Pathology, vol. 4, no. 5, pp. 476-495, 2011.
76. S. Roos, T. L. Powell, and T. Jansson, "Placental mTOR links maternal nutrient availability to fetal growth, " Biochemical Society Transactions, vol. 37, no. 1, pp. 295-298, 2009.
77. S. Roos, O. Lagerlöf, M. Wennergren, T. L. Powell, and T. Jansson, "Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling, " American Journal of Physiology-Cell Physiology, vol. 297, no. 3, pp. C723-C731, 2009.
78. C. M. Scifres and D. M. Nelson, "Intrauterine growth restriction, human placental development and trophoblast cell death, " Journal of Physiology, vol. 587, no. 14, pp. 3453-3458, 2009.
79. S. Roos, Y. Kanai, P. D. Prasad, T. L. Powell, and T. Jansson, "Regulation of placental amino acid transporter activity by mammalian target of rapamycin, " American Journal of Physiology: Cell Physiology, vol. 296, no. 1, pp. C142-C150, 2009.
80. S. Roos, O. Lagerlöf, M. Wennergren, T. L. Powell, and T. Jansson, "Regulation of amino acid transporters by glucose and growth factors in cultured primary human trophoblast cells is mediated by mTOR signaling, " The American Journal of Physiology-Cell Physiology, vol. 297, no. 3, pp. C723-C731, 2009.
81. S. Roos, N. Jansson, I. Palmberg, K. Säljö, T. L. Powell, and T. Jansson, "Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth, " The Journal of Physiology, vol. 582, no. 1, pp. 449-459, 2007.
82. E. B. Gordon, G. T. Hart, T. M. Tran et al., "Inhibiting the Mammalian target of rapamycin blocks the development of experimental cerebralmalaria, "mBio, vol. 6, no. 3, pp. 1-17, 2015.
83. F. I. Onditi, O. W. Nyamongo, C. O. Omwandho et al., "Parasite accumulation in placenta of non-immune baboons during Plasmodium knowlesi infection, "Malaria Journal, vol. 14, article 118, 2015.
84. G. Dimasuay, T. Jansson, J. Glazier, S. Rogerson, and P. Boeuf, "Placental mTOR signaling and fetal growth restriction in placental malaria (#132), " in Proceedings of the Lorne Infection and Immunity Conference, Lorne, Australia, February 2014.
85. R. Chen, Y. Zou, D. Mao et al., "The general amino acid control pathway regulates mTOR and autophagy during serum/glutamine starvation, " The Journal of Cell Biology, vol. 206, no. 2, pp. 173-182, 2014.
86. S. H. Landis, V. Lokomba, C. V. Ananth et al., "Impact of maternal malaria and under-nutrition on intrauterine growth restriction: a prospective ultrasound study in Democratic Republic of Congo, " Epidemiology&Infection, vol. 137, no. 2, pp. 294-304, 2009.
87. J. B. Griffin, V. Lokomba, S. H. Landis et al., "Plasmodium falciparum parasitaemia in the first half of pregnancy, uterine and umbilical artery blood flow, and foetal growth: a longitudinal Doppler ultrasound study, "Malaria Journal, vol. 11, no. 1, article 319, 2012.
88. Y. Aiko, D. J. Askew, S. Aramaki et al., "Differential levels of amino acid transporters system L and ASCT2, and the mTOR protein in placenta of preeclampsia and IUGR, "BMC Pregnancy and Childbirth, vol. 14, no. 1, article 181, 12 pages, 2014.
89. S. Roos, T. L. Powell, and T. Jansson, "Placental mTOR links maternal nutrient availability to fetal growth, " Biochemical Society Transactions, vol. 37, no. 1, pp. 295-298, 2009.